Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 29.45
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Wiltrom Co., Ltd. researches, develops, manufactures, and sells a range of implantable medical devices in Taiwan and internationally. The company's products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. Wiltrom Co., Ltd. was founded in 2009 and is based in Zhubei, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell